Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Roche brings Pharma Development site to Ontario adding 200 jobs

This article was originally published in Scrip

Executive Summary

Roche is to invest more than $190 million over the next five years into Ontario, Canada. It is expanding its Mississauga facilities to create a new Pharmaceutical Development site, one of six in the world, that will manage operations for all stages of global clinical trials. The expansion will create 200 new jobs in global study management, global data management, and regulatory affairs.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC014103

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel